current strategi manag locoregion metastat gastric carcinoma gastric carcinoma signific caus death worldwid patient prognosi degre gastric wall penetr presenc lymph node metastas locat primari site metastat gastric carcinoma incur chemotherapi rapid pace activ agent cisplatin methotrex mitomycin combin doxorubicin cisplatin eap high respons rate complet respons rate patient metastat gastric carcinoma trial way result etoposide-bas combin leucovorin elf good respons rate toxic eap doxorubicin methotrex famtx regimen excel respons rate patient locoregion carcinoma cur resect rate unsatisfactorili low cur resect improv surviv month patient resect carcinoma signific problem low rate cur resect develop widespread carcinoma cur resect mani attempt postop strategi adjuv chemotherapi ineffect new strategi combin cisplatin efp patient resect gastric carcinoma encourag cur resect rate manag toxic promis result eap patient unresect locoregion carcinoma stomach trial preoper postop eap resect carcinoma stomach way 